Saturday 17 October 2026
Export PETS’s income statement to Excel — free account
PetMed Express, Inc.
PETS Healthcare Pharmaceutical Retailers
PetMed Express, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $179.0 million, down 21.1% from fiscal 2025. In the quarter to June 2026, revenue fell 19.9%, EPS grew 83.0% and free cash flow grew 38.6%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
1.20
0.02
−1.64%
Follow PETS
| Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 5 | 5 | 4 | 4 | 5 | 5 | 7 | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 | 65.38 | 27.98 | 29.42 | 22.48 | 12.50 | 22.40 | 17.07 |
Altman Z-Score |
0.40 | 3.06 | 3.00 | 6.32 | 9.02 | 13.06 | 18.10 | 18.93 | 31.86 | 17.63 |
P/S ratio |
0.27 | 0.38 | 0.35 | 1.33 | 1.91 | 2.32 | 2.03 | 1.67 | 3.06 | 1.64 |
Altman Z″-Score (non-manufacturers) |
(4.59) | 3.51 | 3.27 | 6.89 | 8.70 | 10.70 | 13.80 | 16.33 | 15.77 | 13.46 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 14.61 | 31.08 | 18.74 | 15.79 | 10.63 | 22.87 | 11.13 |
P/Operating CF |
(10.05) | 12.31 | 13.40 | 33.86 | 59.72 | 38.24 | 33.41 | 36.08 | 375.41 | 26.18 |
Beneish M-Score |
(4.77) | (3.11) | (0.80) | (2.66) | (1.19) | (3.40) | (2.42) | (2.61) | (2.36) | (3.99) |
Dividend Safety Score |
36 | — | — | — | — | — | — | — | — | — |
P/B ratio |
1.65 | 1.01 | 0.99 | 2.99 | 4.22 | 4.99 | 4.44 | 3.51 | 7.25 | 4.36 |
Price to Tangible BV |
2.63 | 1.91 | 1.78 | 3.16 | 4.25 | 5.02 | 4.47 | 3.54 | 7.30 | 4.41 |
EV/Sales |
0.15 | 0.14 | 0.15 | 0.91 | 1.50 | 1.93 | 1.66 | 1.31 | 2.78 | 1.40 |
EV/EBITDA |
0.00 | 4.71 | 0.00 | 23.46 | 15.15 | 17.80 | 14.23 | 7.70 | 14.02 | 8.98 |
EV/Operating CF |
(0.93) | 6.69 | 9.30 | 8.10 | 22.14 | 14.64 | 12.18 | 8.25 | 20.35 | 7.39 |
EV/FCF |
(0.80) | (79.94) | (207.00) | 9.99 | 24.45 | 15.59 | 12.95 | 8.37 | 20.74 | 9.53 |
Quick Ratio |
0.45 | 0.91 | 0.81 | 1.84 | 2.01 | 2.70 | 4.42 | 5.53 | 4.43 | 3.30 |
Current Ratio |
0.84 | 1.26 | 1.30 | 2.27 | 2.68 | 3.59 | 5.30 | 6.79 | 5.81 | 4.46 |
Net Debt/EBITDA |
0.97 | (8.16) | 50.00 | (10.85) | (4.11) | (3.60) | (3.12) | (2.08) | (1.44) | (1.51) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.56 | 1.42 | 1.62 | 1.43 | 1.48 | 1.77 | 1.83 | 1.96 | 2.21 | 2.45 |
Operating CF/Net income |
0.50 | (0.75) | (0.58) | 5.41 | 0.99 | 1.68 | 1.50 | 1.20 | 1.00 | 1.98 |
Capex/Depreciation |
(0.13) | (0.62) | (0.64) | (1.48) | (0.64) | (1.00) | (1.02) | (0.28) | (0.33) | (7.75) |
| (100.45%) | (6.90%) | (7.22%) | 4.40% | 14.14% | 17.63% | 19.53% | 30.14% | 35.66% | 26.98% | |
| (49.84%) | (3.94%) | (4.42%) | 2.96% | 10.19% | 13.95% | 16.69% | 26.09% | 30.11% | 23.46% | |
ROIC |
(487.12%) | (3.14%) | (12.31%) | 64.32% | 122.73% | 84.57% | 73.76% | 84.50% | 86.22% | 67.64% |
Return on Tangible Assets |
(320.82%) | (13.95%) | (15.50%) | 5.19% | 15.70% | 16.88% | 19.87% | 27.97% | 32.18% | 25.45% |
Average Days of Receivables |
3.89 | 3.73 | 4.37 | 2.57 | 2.56 | 3.11 | 4.94 | 3.27 | 3.06 | 2.65 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
40.36% | 27.50% | 31.33% | 27.02% | 18.33% | 16.92% | 16.90% | 16.55% | 15.90% | 16.24% |
Intangible Assets out of Total Assets |
0.13 | 0.27 | 0.25 | 0.04 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
0.76% | (2.90%) | 2.51% | 2.67% | 1.67% | 1.09% | 0.99% | 1.09% | 0.94% | 0.78% |
Graham Net Nets |
(0.18) | 0.18 | 0.21 | 0.22 | 0.18 | 0.16 | 0.18 | 0.23 | 0.10 | 0.15 |
Graham Number |
0.00 | 0.00 | 0.00 | 5.51 | 11.27 | 13.76 | 13.67 | 16.55 | 15.35 | 11.07 |
Earnings Yield |
(120.61%) | (7.16%) | (7.92%) | 1.53% | 3.57% | 3.40% | 4.45% | 8.00% | 4.46% | 5.86% |
Free Cash Flow Yield |
(69.20%) | (0.46%) | (0.20%) | 6.85% | 3.22% | 5.34% | 6.33% | 9.41% | 4.37% | 8.98% |
Revenue per Share |
8.56 | 11.02 | 13.44 | 12.21 | 13.50 | 15.13 | 14.18 | 13.85 | 13.46 | 12.32 |
Operating CF per Share |
(1.36) | 0.23 | 0.21 | 1.37 | 0.92 | 2.00 | 1.94 | 2.21 | 1.84 | 2.33 |
Capex per Share |
(0.22) | (0.25) | (0.22) | (0.26) | (0.09) | (0.12) | (0.12) | (0.03) | (0.03) | (0.52) |
Free Cash Flow per Share |
(1.58) | (0.02) | (0.01) | 1.11 | 0.83 | 1.88 | 1.82 | 2.18 | 1.80 | 1.81 |
Cash per Share |
1.02 | 2.66 | 2.71 | 5.13 | 5.51 | 5.92 | 5.18 | 4.91 | 3.83 | 2.90 |
Shareholders Equity per Share |
1.38 | 4.13 | 4.74 | 5.42 | 6.12 | 7.04 | 6.49 | 6.58 | 5.69 | 4.61 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.38 | 4.13 | 4.74 | 5.42 | 6.12 | 7.04 | 6.49 | 6.58 | 5.69 | 4.61 |
Free Cash Flow |
(33.01) | (0.39) | (0.19) | 22.54 | 16.75 | 37.64 | 36.53 | 44.52 | 36.68 | 36.60 |
Working Capital |
(8.47) | 16.10 | 21.49 | 72.92 | 94.75 | 116.25 | 104.68 | 107.81 | 87.13 | 63.43 |
Capital Expenditures |
(4.61) | (5.11) | (4.51) | (5.26) | (1.75) | (2.43) | (2.31) | (0.62) | (0.70) | (10.60) |
Net Current Asset Value |
(8.69) | 15.31 | 20.50 | 72.92 | 94.75 | 114.97 | 103.71 | 106.68 | 86.13 | 62.34 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 37.21 | 16.86 | 19.22 | 15.27 | 8.07 | 14.59 | 9.30 |
Capex to Sales |
0.03 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.04 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 54.42 | 21.43 | 23.11 | 18.62 | 10.25 | 16.09 | 10.87 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.39 | 0.29 | 0.26 | 0.14 | 0.11 | 0.10 | 0.09 | 0.08 | 0.07 | 0.05 |
Cash ROIC |
(65.56%) | (0.28%) | (0.13%) | 10.53% | 7.14% | 14.48% | 15.63% | 18.93% | 18.94% | 24.06% |
Accounts Receivable Turnover |
84.74 | 81.06 | 109.14 | 135.54 | 121.01 | 94.43 | 89.00 | 117.26 | 133.56 | 141.10 |
Accounts Payable Turnover |
5.79 | 5.21 | 6.08 | 6.49 | 5.83 | 7.41 | 11.29 | 11.92 | 11.54 | 16.80 |
Inventory Turnover |
8.64 | 7.05 | 7.96 | 6.65 | 5.84 | 8.38 | 10.34 | 8.42 | 8.08 | 7.42 |
Average Days of Payables |
59.24 | 54.49 | 71.38 | 53.79 | 51.38 | 65.83 | 35.37 | 31.58 | 31.68 | 32.71 |
Days of Inventory on Hand |
38.56 | 37.47 | 55.05 | 40.59 | 60.64 | 57.30 | 32.18 | 41.47 | 48.40 | 43.47 |
Average Receivables |
2.11 | 2.80 | 2.51 | 1.83 | 2.25 | 3.22 | 3.19 | 2.42 | 2.05 | 1.77 |
Average Payables |
22.24 | 30.29 | 31.12 | 26.35 | 33.52 | 29.60 | 17.97 | 15.77 | 15.25 | 10.11 |
Average Inventory |
14.91 | 22.38 | 23.79 | 25.74 | 33.44 | 26.15 | 19.63 | 22.35 | 21.78 | 22.91 |
Average Assets |
114.95 | 159.29 | 168.68 | 173.59 | 183.60 | 171.41 | 154.88 | 144.63 | 123.82 | 101.54 |
Average Common Equity |
57.03 | 90.92 | 103.34 | 116.70 | 132.36 | 135.64 | 132.34 | 125.20 | 104.54 | 88.27 |
Columns are period end dates